Relation of adrenergic receptors, which have roles in gastroprotective and anti-inflammatory effect of adrenal gland hormones, with cyclooxygenase enzyme levels in rats

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 129-134

  Suleyman, H ^a   Dursun, H ^b   Bilici, M ^a   Cadirci, E ^a   Halici, Z ^a   Gulaboglu, M ^b   Albayrak, F ^b  

^a ATATURK UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

Adrenaline; Adrenergic receptors; Cyclooxygenase; Prednisolone

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOXAZOSIN; METOPROLOL; PREDNISOLONE; PROPRANOLOL; PROSTAGLANDIN SYNTHASE; YOHIMBINE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; MALE; NONHUMAN; RAT; STOMACH;

ADRENALECTOMY; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPINEPHRINE; MALE; PREDNISOLONE; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-2; STOMACH;

EID: 75749115585     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Burke A, Smyth E, Fitzgerald GA. Analgesic- antipyretic agents; pharmacotherapy of gout. In Godman and Gilman's the Pharmacological Basis of Therapeutics. L. Brunton (ed). New-York, Mc Graw-Hill, 2006: pp. 671-717.
2. - secretion in stomach. J Physiol Pharmacol 2006; 57: 661-676.
3. Mitchell JA, Warner TD. Cyclooxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Br J Pharmacol 1999; 128: 1121-1132.
4. Suleyman H, Demircan B, Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep 2007; 59: 247-258.
5. Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res 2000; 49: 367-392.
6. van Staa TP, Rietbrock S, Setakis E, Leufkens HG. Does the varied use of NSAIDs explain the differences in the risk of myocardial infarction? J Intern Med 2008; 264: 481-492.
7. Laine L. Gastrointestinal effects of NSAIDs and coxibs. J Pain Symptom Manage 2003; 25: S32-S40.
8. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693-11697.
9. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 1997; 112: 1000-1016.
10. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 2005; 56(Suppl 5): 33-55.
11. 2. Biol Pharm Bull 2002; 25: 14-18.
12. Suleyman H, Akcay F, Altinkaynak K. The effect of nimesulide on the indomethacin- and ethanol-induced gastric ulcer in rats. Pharmacol Res 2002; 45: 155-158.
13. Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Keles S, Gocer F. Indirect role of α2-adrenoreceptors in anti-ulcer effect mechanism of nimesulide in rats. Naunyn Schmiedebergs Arch Pharmacol 2007; 375: 189-198.
14. Takeuchi K, Nishiwaki H, Okada M, Niida H, Okabe S. Bilateral adrenalectomy worsens gastric mucosal lesions induced by indomethacin in the rat. Role of enhanced gastric motility. Gastroenterology 1989; 97: 284-293.
15. Suleyman H, Halici Z, Cadirci E, Hacimuftuoglu A, Bilen H. Indirect role of β-2 adrenergic receptors in antiinflammatory effect mechanism of NSAI drugs. J Physiol Pharmacol 2008; 59: 661-672.
16. Suleyman H, Cadirci E, Albayrak A, et al. The reason of the aggravation of the diseases which are going with inflammation and ineffectiveness of NSAIDs on them in rainy weather. Pharm Rep 2009; 61: 514-519.
17. Rakha MK, Nabil ZI, Hussein AA. Cardioactive and vasoactive effects of natural wild honey against cardiac malperformance induced by hyperadrenergic activity. J Med Food 2008; 11: 91-98.
18. Kirimoto T, Nakano K, Irimura K, et al. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. BJU Int 2007; 100: 935-959.
19. Bennett M. One hundred years of adrenaline: the discovery of autoreceptors. Clin Auton Res 1999; 9: 145-159.
20. Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenal corticosteroids and their synthetic analogs; inhibitors of the synthesis and actions pd adrenocortical hormones. In Godman and Gilman's the Pharmacological Basis of Therapeutics. L. Brunton (ed). New-York, Mc Graw-Hill, 2006, pp. 1587-1612.
21. Leung DY, Hanifin JM, Charlesworth EN, et al. Disease management of atopic dermatitis: a practice parameter. Joint Task Force on practice parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Council of Allergy, Asthma and Immunology. Work Group on Atopic Dermatitis. Ann Allergy Asthma Immunol 1997; 79(3): 197-211.
22. Suleyman H, Demircan B, Gocer F, Halici Z, Hacimuftuoglu A. Role of adrenal gland hormones in the mechanism of antiulcer action of nimesulide and ranitidine. Pol J Pharmacol 2004; 56: 799-804.
23. Perlini S, Ferrero I, Palladini G, et al. Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. Hypertension 2006; 48: 93-97.
24. Li C, Sekiyama H, Hayashida M, et al. Effects of topical application of clonidine cream on pain behaviors and spinal Fos protein expression in rat models of neuropathic pain, postoperative pain, and inflammatory pain. Anesthesiology 2007; 107: 486-494.
25. Bradford MM. Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
26. Elenkov IJ, Chrousos GP. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002; 966: 290-303.
27. Filaretova L, Tanaka A, Komoike Y, Takeuchi K. Selective cyclooxygenase-2 inhibitor induces gastric mucosal damage in adrenalectomized rats. Inflammopharmacology 2002; 10: 413-422.
28. Kuehl FAJr, Egan RW. Prostaglandins, arachidonic acid, and inflammation. Science 1980; 210: 978-984.
29. Gadek-Michalska A, Bugajski AJ, Bugajski J. Prostaglandins and interleukin-1beta in the hypothalamicpituitary-adrenal response to systemic phenylephrine under basal and stress conditions. J Physiol Pharmacol 2008; 59: 563-575.
30. Yono M, Foster HE Jr, Shin D, Takahashi W, Pouresmail M, Latifpour J. Doxazosin treatment causes differential alterations of α 1-adrenoceptor subtypes in the rat kidney, heart and aorta. Life Sci 2004; 75: 2605-2614.
31. Le AD, Harding S, Juzytsch W, Funk D, Shaham Y. Role of α-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Psychopharmacology (Berlin) 2005; 179: 366-373.
32. Young RA, Brogden RN. Doxazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in mild or moderate hypertension. Drugs 1988; 35: 525-541.
33. Yonezawa A, Yoshizumii M, Ebiko M, Amano T, Kimura Y, Sakurada S. Long-lasting effects of yohimbine on the ejaculatory function in male dogs. Biomed Res 2005; 26: 201-206.
34. Talbert RL. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure. Heart Fail Rev 2004; 9: 131-137.
35. Ishizaki T. Likely explanation for longer duration of pharmacological (antianginal) effects of propranolol in relation to its short half-life. Res Commun Chem Pathol Pharmacol 1980; 27: 223-239.
36. Gyires K, Mullner K, Furst S, Ronai AZ. α-2 adrenergic and opioid receptor-mediated gastroprotection. J Physiol (Paris) 2000; 94: 117-121.
37. Kiro A, Zahavi I, Marcus H, Dinari G. L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an α-2-adrenergic mechanism. Life Sci 1992; 51: 1151-1156.
38. DiJoseph JF, Eash JR, Mir GN. Gastric antisecretory and antiulcer effects of WHR1582A, a compound exerting α-2 adrenoceptor agonist activity. J Pharmacol Exp Ther 1987; 241: 97-102.
39. Del Soldato P. Gastric lesion-preventing or -potentiating activity of clonidine in rats. Jpn J Pharmacol 1986; 41: 257-259.
40. Fulop K, Zadori Z, Ronai AZ, Gyires K. Characterisation of α2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence. Eur J Pharmacol 2005; 528: 150-157.
41. Kataoka H, Horie Y, Koyama R, Nakatsugi S, Furukawa M. Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach. Dig Dis Sci 2000; 45: 1366-1375.
42. Black HE. The effects of steroids upon the gastrointestinal tract. Toxicol Pathol 1988; 16: 213-222.
43. Wallace JL. Glucocorticoid-induced gastric mucosal damage: inhibition of leukotriene, but not prostaglandin biosynthesis. Prostaglandins 1987; 34: 311-323.
44. Weusten BL, Jacobs JW, Bijlsma JW. Corticosteroid pulse therapy in active rheumatoid arthritis. Semin Arthritis Rheum 1993; 23: 183-192.
45. Izeboud CA, Mocking JA, Monshouwer M, Van Miert AS, Witkamp RF. Participation of β-adrenergic receptors on macrophages in modulation of LPS-induced cytokine release. J Recept Signal Transduct Res 1999; 19: 191-202.